Hosted by HMS Center for Bioethics | Ethics in Research & Biotechnology
Lorenz Studer, MD
DIrector, Center for Stem Cell Biology
Memorial Sloan Kettering Cancer Center
Insoo Hyun, PhD
DIrector of Research Ethics, Center for Bioethics
Harvard Medical School
Professor of Bioethics
Case Western Reserve University School of Medicine
Lorenz Studer's lab has worked for over a decade on developing a cell therapy for Parkinson's disease (PD). Recently Dr. Studer has demonstrated that lab-grown dopamine nerve cells derived from human stem cells can efficiently engraft and function in animal models of PD. Based on these results, the Studer lab is pursuing the development of a clinical-grade dopamine neuron cell product and is in the process of generating the data necessary for an investigational new drug application from the FDA, which is required for the first human clinical use of human ESC-derived dopamine neurons.
This consortium will examine the major milestones of Dr. Studer's work as he advances his promising cell-based approach to treating Parkinson's disease, from preclinical studies to clinical trials. Together, Dr. Insoo Hyun and Dr. Studer will discuss the ethical issues that track alongside this exciting scientific journey to the clinic and will invite the audience to participate in interactive discussion.
Register and add upcoing seesions to your calendar now:
How Brain Organoids Can Help Advance COVID-19 Research
Right to Try Laws and Their Impact on Research and Patient Access